Predictive tools for continuous distillation design lag behind upstream pharmaceutical synthesis─including AI-enabled digital tooling for retrosynthetic route design─leaving column specification dependent on computationally expensive simulation or extensive experimentation. This work presents a machine-learning surrogate framework trained entirely on first-principles mechanistic simulations, requiring no experimental distillation data, and eliminating the need for commercial tools such as ChemCad or AspenPlus. Three surrogate models for binary tert-butylamine/alcohol systems (methanol, ethanol, isopropanol) predict distillate and bottoms compositions with mean absolute errors below 0.005 mol/mol and R2 > 0.999, completing a single prediction in under 1 ms─a 24-fold speedup. A coupled Pareto optimizer returns capital-versus-operating-cost trade-off curves in under 10 s, with over 93% of designs verified within ±0.010 mol/mol. Applied to a pharmaceutical case study, the framework correctly identifies isopropanol as the optimal solvent without prior thermodynamic knowledge. The system-agnostic architecture could readily integrate with open-source large language model platforms to further lower the barrier to implementation.
No takes yet. Share an insight, caveat, or question.
Turnage et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: